NIAGEN BIOSCIENCE, INC. Loss Contingency, New Claims Filed, Number
NIAGEN BIOSCIENCE, INC. (NAGE) reported Loss Contingency, New Claims Filed, Number of 2 claim for the 1-month period ending 2026-06-16, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Commitment and Contingencies › Loss Contingency
us-gaap:LossContingencyNewClaimsFiledNumber · last filed 2026-08-04
- 2026-06-16: Loss Contingency, New Claims Filed, Number 1 month 2.00 claim.
- 2018-11-27: Loss Contingency, New Claims Filed, Number 23 month 5.00 claim.
| Period end | Loss Contingency, New Claims Filed, Number 1 month | Loss Contingency, New Claims Filed, Number 23 month |
|---|---|---|
| 2026-06-16 | 2.00 claim 10-Q · filed 2026-08-04 | |
| 2018-11-27 | 5.00 claim 10-Q · filed 2025-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |